Perioperative management of the severely obese patient: A selective pathophysiological review

Canadian Journal of Anesthesia

Volumn 59, Issue 10, 2012, Pages 974-996

  Cullen, Aidan ^a   Ferguson, Andrew ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b CRAIGAVON AREA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LEPTIN;

ADIPOCYTE; ANALGESIA; ANESTHETIC RECOVERY; ARTICLE; ASPIRATION; BLOOD PRESSURE MONITORING; BODY POSITION; BODY POSTURE; BRACHIAL PLEXUS ANESTHESIA; BREATHING DISORDER; CARDIOVASCULAR RISK; CLINICAL PHARMACOLOGY; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; EPICARDIUM; FAT CONTENT; GASTROINTESTINAL TRACT FUNCTION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; INFECTION RISK; LARYNGEAL MASK; LARYNGOSCOPE; LARYNGOSCOPY; LITHOTOMY POSITION; LUNG VENTILATION; METABOLIC SYNDROME X; MOBILIZATION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OBESITY; OBESITY HYPOVENTILATION SYNDROME; OXYGENATION; PATHOPHYSIOLOGY; PATIENT POSITIONING; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE CARE; PRIORITY JOURNAL; REGIONAL ANESTHESIA; RESPIRATORY CARE; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; RISK ASSESSMENT; SLEEP APNEA SYNDROME; SUPINE POSITION; THROMBOSIS PREVENTION; TISSUE BLOOD FLOW; TRENDELENBURG POSITION; UPPER GASTROINTESTINAL TRACT; VASCULAR ACCESS; VENOUS THROMBOEMBOLISM;

ANESTHESIA; ANESTHESIOLOGY; HUMANS; OBESITY; PERIOPERATIVE CARE; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, OPERATIVE;

EID: 84866728985     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-012-9760-2     Document Type: Article

References (138)

1. Shields M, Tremblay MS, Laviolette M, Craig CL, Janssen I, Gorber SC. Fitness of Canadian adults: results from the 2007-2009 Canadian Health Measures Survey. Health Rep 2010; 21: 21-35.
2. Sassi F, Devaux M, Cecchini M, Rusticelli E. The obesity epidemic: analysis of past and projected future trends in selected OECD countries. OECD Health Working Papers 2009; DOI: 10.1787/225215402672.
3. Kosmala W, Jedrzejuk D, Derzhko R, Przewlocka-Kosmala M, Mysiak A, Bednarek-Tupikowska G. Left ventricular function impairment in patients with normal-weight obesity: contribution of abdominal fat deposition, profibrotic state, reduced insulin sensitivity and proinflammatory activation. Circ Cardiovasc Imaging 2012; 5: 349-56.
4. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31: 737-46.
5. Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197-209.
6. Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96.
7. Wronska A, Kmiec Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf) 2012; 205: 194-208.
8. Summer R, Walsh K, Medoff BD. Obesity and pulmonary arterial hypertension: is adiponectin the molecular link between these conditions? Pulm Circ 2011; 1: 440-7.
9. Flynn C, Bakris GL. Interaction between adiponectin and aldosterone. Cardiorenal Med 2011; 1: 96-101.
10. Sun S, Ji Y, Kersten S, Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr 2012; DOI: 10.1146/annurev-nutr-071811- 150623.
11. Martins AR, Nachbar RT, Gorjao R, et al. Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis 2012; 11: 30.
12. Bagi Z, Feher A, Cassuto J. Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol 2012; 165: 544-60.
13. Houben AJ, Eringa EC, Jonk AM, Serne EH, Smulders YM, Stehouwer CD. Perivascular fat and the microcirculation: relevance to insulin resistance, diabetes, and cardiovascular disease. Curr Cardiovasc Risk Rep 2011; 6: 80-90.
14. Konishi M, Sugiyama S, Sugamura K, et al. Accumulation of pericardial fat correlates with left ventricular diastolic dysfunction in patients with normal ejection fraction. J Cardiol 2012; 59: 344-51.
15. Sotornik R, Brassard P, Martin E, Yale P, Carpentier AC, Ardilouze JL. Update on adipose tissue blood flow regulation. Am J Physiol Endocrinol Metab 2012; 302: E1157-70.
16. Oda E. Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 2012; 49: 89-95.
17. Huang KC, Lee LT, Chen CY, Sung PK. All-cause and cardiovascular disease mortality increased with metabolic syndrome in Taiwanese. Obesity (Silver Spring) 2008; 16: 684-9.
18. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066-72.
19. Berwick ZC, Dick GM, Tune JD. Heart of the matter: coronary dysfunction in metabolic syndrome. J Mol Cell Cardiol 2012; 52: 848-56.
20. Dincer UD, Araiza AG, Knudson JD, Molina PE, Tune JD. Sensitization of coronary a -adrenoceptor vasoconstriction in the prediabetic metabolic syndrome. Microcirculation 2006; 13: 587-95.
21. Zhang C, Knudson JD, Setty S, et al. Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors. Am J Physiol Heart Circ Physiol 2005; 288: H2154-62.
22. Rider OJ, Petersen SE, Francis JM, et al. Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity. Heart 2011; 97: 203-8.
23. Roos CJ, Quax PH, Jukema JW. Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease. Biomark Med 2012; 6: 35-52.
24. Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens 2011; 26: 281-7.
25. Messaoudi S, Azibani F, Delcayre C, Jaisser F. Aldosterone, mineralocorticoid receptor, and heart failure. Mol Cell Endocrinol 2012; 350: 266-72.
26. Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, O'Moore-Sullivan T, Marwick TH. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. JACC Cardiovasc Imaging 2011; 4: 1239-49.
27. Ito K, Date T, Kawai M, et al. Morphological change of left atrium in obese individuals. Int J Cardiol 2011; 152: 117-9.
28. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of newonset atrial fibrillation. JAMA 2004; 292: 2471-7.
29. Lin YK, Chen YC, Chang SL, et al. Heart failure epicardial fat increases atrial arrhythmogenesis. Int J Cardiol 2012; DOI: 10.1016/j.ijcard.2012.05.009.
30. Baena-Diez JM, Byram AO, Grau M, et al. Obesity is an independent risk factor for heart failure: Zona Franca Cohort Study. Clin Cardiol 2010; 33: 760-4.
31. Timoh T, Bloom ME, Siegel RR, Wagman G, Lanier GM, Vittorio TJ. A perspective on obesity cardiomyopathy. Obes Res Clin Pract 2012; DOI:10.1016/j.orcp.2012.02.011.
32. Huang CY, Lee SD. Possible pathophysiology of heart failure in obesity: cardiac apoptosis. BioMedicine 2012; 2: 36-40.
33. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.
34. Satpathy C, Mishra TK, Satpathy R, Satpathy HK, Barone E. Diagnosis and management of diastolic dysfunction and heart failure. Am Fam Physician 2006; 73: 841-6.
35. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Hearth Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: e418- 500.
36. American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 2003; 167: 211-77.
37. Bhat G, Daley K, Dugan M, Larson G. Preoperative evaluation for bariatric surgery using transesophageal dobutamine stress echocardiography. Obes Surg 2004; 14: 948-51.
38. Lerakis S, Kalogeropoulos AP, El-Chami MF, et al. Transthoracic dobutamine stress echocardiography in patients undergoing bariatric surgery. Obes Surg 2007; 17: 1475-81.
39. Matyal R, Skubas NJ, Sheman SK, Mahmood F. Perioperative assessment of diastolic dysfunction. Anesth Analg 2011; 113: 449-72.
40. Daniels LB, Clopton P, Bhalla V, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 2006; 151: 999-1005.
41. Beleigoli A, Diniz M, Nunes M, et al. Reduced brain natriuretic peptide levels in class III obesity: the role of metabolic and cardiovascular factors. Obes Facts 2011; 4: 427-32.
42. POISE Study Group, Devereaux PJ, Yang H, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-47.
43. von Homeyer P, Schwinn DA. Pharmacogenomics of b-adrenergic receptor physiology and response to b-blockade. Anesth Analg 2011; 113: 1305-18.
44. Uzunlulu M, Oguz A, Yorulmaz E. The effect of carvedilol on metabolic parameters in patients with metabolic syndrome. Int Heart J 2006; 47: 421-30.
45. Pitt B. The role of mineralocorticoid receptor antagonists in patients with American College of Cardiology/American Heart Association stage B heart failure. Heart Fail Clin 2012; 8: 247-53.
46. Matsumoto S, Takebayashi K, Aso Y. The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy. Metabolism 2006; 55: 1645-52.
47. Ashburn DD, DeAntonio A, Reed MJ. Pulmonary system and obesity. Crit Care Clin 2010; 26: 597-602.
48. Littleton SW. Impact of obesity on respiratory function. Respirology 2012; 17: 43-9.
49. Barbalho-Moulim MC, Miguel GPS, Forti EMP, Campos FDA, Costa D. Effects of preoperative inspiratory muscle training in obese women undergoing open bariatric surgery: respiratory muscle strength, lung volumes, and diaphragmatic excursion. Clinics 2011; 66: 1721-7.
50. Lopez PP, Stefan B, Schulman CI, Byers PM. Prevalence of sleep apnea in morbidly obese patients who presented for weight loss surgery evaluation: more evidence for routine screening for obstructive sleep apnea before weight loss surgery. Am Surg 2008; 74: 834-8.
51. Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation syndrome. Chest 2007; 132: 1322-36.
52. Gross JB, Bachenberg KL, Benumof JL, American Society of Anesthesiologists Task Force on Perioperative Management, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006; 104: 1081-93.
53. Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. Can J Anesth 2010; 57: 423-38.
54. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 2008; 108: 812-21.
55. Piper AJ. Obesity hypoventilation syndrome - the big and the breathless. Sleep Med Rev 2011; 15: 79-89.
56. Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med 2011; 183: 292-8.
57. Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004; 116: 1-7.
58. Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventilation syndrome. Chest 2001; 120: 377-83.
59. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007; 11: 117-24.
60. Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition 2009; 25: 1150-6.
61. Valentino D, Sriram K, Shankar P. Update on micronutrients in bariatric surgery. Curr Opin Clin Nutr Metab Care 2011; 14: 635-41.
62. Schweiger C, Weiss R, Berry E, Keidar A. Nutritional deficiencies in bariatric surgery candidates. Obes Surg 2010; 20: 193-7.
63. Damms-Machado A, Friedrich A, Kramer KM, et al. Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy. Obes Surg 2012; 22: 881-9.
64. Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth 2010; 105(Suppl 1): i16-23.
65. Leykin Y, Miotto L, Pellis T. Pharmacokinetic considerations in the obese. Best Pract Res Clin Anaesthesiol 2011; 25: 27-36.
66. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44: 1051-65.
67. Ingrande J, Brodsky JB, Lemmens HJ. Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg 2011; 113: 57-62.
68. van Kralingen S, van de Garde EM, Knibbe CA, et al. Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients. Br J Clin Pharmacol 2011; 71: 34-40.
69. Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients. Anaesthesia 2011; 66: 721-5.
70. Lim W. Using low molecular weight heparin in special patient populations. J Thromb Thrombolysis 2010; 29: 233-40.
71. McLeay SC, Morrish GA, Kirkpatrick CM, Green B. Encouraging the move towards predictive population models for the obese using propofol as a motivating example. Pharm Res 2009; 26: 1626-34.
72. Cortinez LI, Anderson BJ, Penna A, et al. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth 2010; 105: 448-56.
73. Meyhoff CS, Lund J, Jenstrup MT, et al. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg 2009; 109: 787-92.
74. Rondina MT, Wheeler M, Rodgers GM, Draper L, Pendleton RC. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-ill patients. Thromb Res 2010; 125: 220-3.
75. Brusasco C, Corradi F, Zattoni PL, Launo C, Leykin Y, Palermo S. Ultrasound-guided central venous cannulation in bariatric patients. Obes Surg 2009; 19: 1365-70.
76. Gregg SC, Murthi SB, Sisley AC, Stein DM, Scalea TM. Ultrasound- guided peripheral intravenous access in the intensive care unit. J Crit Care 2010; 25: 514-9.
77. McGrath TM, Farabaugh EA, Pickett MJ, Wagner DK, Griswold-Theodorson S. Obesity hinders ultrasound visualization of the subclavian vein: implications for central venous access. J Vasc Access 2012; 13: 246-50.
78. Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011; 8: 340-7.
79. Buchholz V, Berkenstadt H, Goitein D, Dickman R, Bernstine H, Rubin M. Gastric emptying is not prolonged in obese patients. Surg Obes Relat Dis 2012; . DOI:10.1016/j.soard.2012.03.008.
80. Menon S, Trudgill N. Risk factors in the aetiology of hiatus hernia: a meta-analysis. Eur J Gastroenterol Hepatol 2011; 23: 133-8.
81. de Leon A, Thorn SE, Wattwil M. High-resolution solid-state manometry of the upper and lower esophageal sphincters during anesthesia induction: a comparison between obese and nonobese patients. Anesth Analg 2010; 111: 149-53.
82. de Leon A, Thorn SE, Raoof M, Ottosson J, Wattwil M. Effects of different respiratory maneuvers on esophageal sphincters in obese patients before and during anesthesia. Acta Anaesthesiol Scand 2010; 54: 1204-9.
83. Cook TM, Woodall N, Fourth National Audit Project. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1: Anaesthesia. Br J Anaesth 2011; 106: 617-31.
84. Kim WH, Ahn HJ, Lee CJ, et al. Neck circumference to thyromental distance ratio: a new predictor of difficult intubation in obese patients. Br J Anaesth 2011; 106: 743-8.
85. Abdallah R, Galway U, You J, Kurz A, Sessler DI, Doyle DJ. A randomized comparison between the Pentax AWS video laryngoscope and the Macintosh laryngoscope in morbidly obese patients. Anesth Analg 2011; 113: 1082-7.
86. Abdelmalak BB, Bernstein E, Egan C, et al. GlideScope® vs flexible fibreoptic scope for elective intubation in obese patients. Anaesthesia 2011; 66: 550-5.
87. Andersen LH, Rovsing L, Olsen KS. GlideScope videolaryngoscope vs. Macintosh direct laryngoscope for intubation of morbidly obese patients: a randomized trial. Acta Anaesthesiol Scand 2011; 55: 1090-7.
88. Moore AR, Schricker T, Court O. Awake videolaryngoscopyassisted tracheal intubation of the morbidly obese. Anaesthesia 2012; 67: 232-5.
89. Ndoko SK, Amathieu R, Tual L, et al. Tracheal intubation of morbidly obese patients: a randomized trial comparing performance of Macintosh and AirtraqTM laryngoscopes. Br J Anaesth 2008; 100: 263-8.
90. Dhonneur G, Abdi W, Ndoko SK, et al. Video-assisted versus conventional tracheal intubation in morbidly obese patients. Obes Surg 2009; 19: 1096-101.
91. Yildiz TS, Ozdamar D, Arslan I, Solak M, Toker K. The LMA CTrachTM in morbidly obese and lean patients undergoing gynecological procedures: a comparative study. J Anesth 2010; 24: 849-53.
92. Arslan ZI, Ozdamar D, Yildiz TS, Solak ZM, Toker K. Tracheal intubation in morbidly obese patients: a comparison of the Intubating Laryngeal Mask AirwayTM and Laryngeal Mask Airway CTrachTM. Anaesthesia 2012; 67: 261-5.
93. Weber U, Oguz R, Potura LA, Kimberger O, Kober A, Tschernko E. Comparison of the i-gel and the LMA-Unique laryngeal mask airway in patients with mild to moderate obesity during elective short-term surgery. Anaesthesia 2011; 66: 481-7.
94. Herriger A, Frascarolo P, Spahn DR, Magnusson L. The effect of positive airway pressure during pre-oxygenation and induction of anaesthesia upon duration of non-hypoxic apnoea. Anaesthesia 2004; 59: 243-7.
95. Futier E, Constantin JM, Pelosi P, et al. Noninvasive ventilation and alveolar recruitment maneuver improve respiratory function during and after intubation of morbidly obese patients: a randomized controlled study. Anesthesiology 2011; 114: 1354-63.
96. Futier E, Constantin JM, Pelosi P, et al. Intraoperative recruitment maneuver reverses detrimental pneumoperitoneuminduced respiratory effects in healthy weight and obese patients undergoing laparoscopy. Anesthesiology 2010; 113: 1310-9.
97. Chalhoub V, Yazigi A, Sleilaty G, et al. Effect of vital capacity manoeuvres on arterial oxygenation in morbidly obese patients undergoing open bariatric surgery. Eur J Anaesthesiol 2007; 24: 283-8.
98. Talab HF, Zabani IA, Abdelrahman HS, et al. Intraoperative ventilatory strategies for prevention of pulmonary atelectasis in obese patients undergoing laparoscopic bariatric surgery. Anesth Analg 2009; 109: 1511-6.
99. Almarakbi WA, Fawzi HM, Alhashemi JA. Effects of four intraoperative ventilatory strategies on respiratory compliance and gas exchange during laparoscopic gastric banding in obese patients. Br J Anaesth 2009; 102: 862-8.
100. De Baerdemaeker LE, Van der Herten C, Gillardin JM, Pattyn P, Mortier EP, Szegedi LL. Comparison of volume-controlled and pressure-controlled ventilation during laparoscopic gastric banding in morbidly obese patients. Obes Surg 2008; 18: 680-5.
101. Cadi P, Guenoun T, Journois D, Chevallier JM, Diehl JL, Safran D. Pressure-controlled ventilation improves oxygenation during laparoscopic obesity surgery compared with volumecontrolled ventilation. Br J Anaesth 2008; 100: 709-16.
102. Brodsky JB. Positioning the morbidly obese patient for anesthesia. Obes Surg 2002; 12: 751-8.
103. Tsueda K, Debrand M, Zeok SS, Wright BD, Griffin WO. Obesity supine death syndrome: reports of two morbidly obese patients. Anesth Analg 1979; 58: 345-7.
104. Jafari B, Mohsenin V. Overnight rostral fluid shift in obstructive sleep apnea: does it affect the severity of sleep-disordered breathing? Chest 2011; 140: 991-7.
105. Pelosi P, Croci M, Calappi E, et al. Prone positioning improves pulmonary function in obese patients during general anesthesia. Anesth Analg 1996; 83: 578-83.
106. Cotter JT, Nielsen KC, Guller U, et al. Increased body mass index and ASA physical status IV are risk factors for block failure in ambulatory surgery - an analysis of 9,342 blocks. Can J Anesth 2004; 51: 810-6.
107. Franco CD, Gloss FJ, Voronov G, Tyler SG, Stojiljkovic LS. Supraclavicular block in the obese population: an analysis of 2020 blocks. Anesth Analg 2006; 102: 1252-4.
108. Schwemmer U, Papenfuss T, Greim C, Brederlau J, Roewer N. Ultrasound-guided interscalene brachial plexus anaesthesia: differences in success between patients of normal and excessive weight. Ultraschall Med 2006; 27: 245-50.
109. Hanouz JL, Grandin W, Lesage A, Oriot G, Bonnieux D, Gerard JL. Multiple injection axillary brachial plexus block: influence of obesity on failure rate and incidence of acute complications. Anesth Analg 2010; 111: 230-3.
110. Al-Nasser B. Review of interscalene block for postoperative analgesia after shoulder surgery in obese patients. Acta Anaesthesiol Taiwan 2012; 50: 29-34.
111. Schroeder K, Andrei AC, Furlong MJ, Donnelly MJ, Han S, Becker AM. The perioperative effect of increased body mass index on peripheral nerve blockade: an analysis of 528 ultrasound guided interscalene blocks. Rev Bras Anestesiol 2012; 62: 28-38.
112. Chin KJ, Perlas A. Ultrasonography of the lumbar spine for neuraxial and lumbar plexus blocks. Curr Opin Anaesthesiol 2011; 24: 567-72.
113. Chin KJ, Perlas A, Chan V, Brown-Shreves D, Koshkin A, Vaishnav V. Ultrasound imaging facilitates spinal anesthesia in adults with difficult surface anatomic landmarks. Anesthesiology 2011; 115: 94-101.
114. Balki M, Lee Y, Halpern S, Carvalho JC. Ultrasound imaging of the lumbar spine in the transverse plane: the correlation between estimated and actual depth to the epidural space in obese parturients. Anesth Analg 2009; 108: 1876-81.
115. von Ungern-Sternberg BS, Regli A, Schneider MC, Kunz F, Reber A. Effect of obesity and site of surgery on perioperative lung volumes. Br J Anaesth 2004; 92: 202-7.
116. Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuroniuminduced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth 2012; 108: 236-9.
117. Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anesth 2011; 58: 944-7.
118. Nazar C, de la Cuadra JC, Munoz H. Neuromuscular blockade monitoring in obese patients. Eur J Anaesthesiol 2005; 22: 36 (A131).
119. Ahmad S, Nagle A, McCarthy RJ, Fitzgerald PC, Sullivan JT, Prystowsky J. Postoperative hypoxemia in morbidly obese patients with and without obstructive sleep apnea undergoing laparoscopic bariatric surgery. Anesth Analg 2008; 107: 138-43.
120. Gallagher SF, Haines KL, Osterlund LG, Mullen M, Downs JB. Postoperative hypoxemia: common, undetected, and unsuspected after bariatric surgery. J Surg Res 2010; 159: 622-6.
121. Hofer RE, Kai T, Decker PA, Warner DO. Obesity as a risk factor for unanticipated admissions after ambulatory surgery. Mayo Clin Proc 2008; 83: 908-16.
122. Gaszynski T, Tokarz A, Piotrowski D, Machala W. Boussignac CPAP in the postoperative period in morbidly obese patients. Obes Surg 2007; 17: 452-6.
123. Wijesinghe M, Williams M, Perrin K, Weatherall M, Beasley R. The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. Chest 2011; 139: 1018-24.
124. Zoremba M, Dette F, Gerlach L, Wolf U, Wulf H. Short-term respiratory physical therapy treatment in the PACU and influence on postoperative lung function in obese adults. Obes Surg 2009; 19: 1346-54.
125. Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg 2008; 106: 1741-8.
126. Pawlik MT, Hansen E, Waldhauser D, Selig C, Kuehnel TS. Clonidine premedication in patients with sleep apnea syndrome: a randomized, double-blind, placebo-controlled study. Anesth Analg 2005; 101: 1374-80.
127. Cabrera Schulmeyer MC, de la Maza de J, Ovalle C, Farias C, Vives I. Analgesic effects of a single preoperative dose of pregabalin after laparoscopic sleeve gastrectomy. Obes Surg 2010; 20: 1678-81.
128. Sollazzi L, Modesti C, Vitale F, et al. Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery. Surg Obes Relat Dis 2009; 5: 67-71.
129. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006; 6: 438-46.
130. Huttunen R, Syrjanen J. Obesity and the risk and outcome of infection. Int J Obes (Lond) 2012; . DOI:10.1038/ijo.2012.62.
131. Cheung KP, Taylor KR, Jameson JM. Immunomodulation at epithelial sites by obesity and metabolic disease. Immunol Res 2012; 52: 182-99.
132. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc 2012; 71: 298-306.
133. Allman-Farinelli MA. Obesity and venous thrombosis: a review. Semin Thromb Hemost 2011; 37: 903-7.
134. Garcia DA, Baglin TP, Weitz JI, Samama MM, American College of Chest Physicians. Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 suppl): e24S-43S.
135. Medico CJ, Walsh P. Pharmacotherapy in the critically ill obese patient. Crit Care Clin 2010; 26: 679-88.
136. Borkgren-Okonek MJ, Hart RW, Pantano JE, et al. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis 2008; 4: 625-31.
137. Kaafarani HM, Shikora SA. Nutritional support of the obese and critically ill obese patient. Surg Clin North Am 2011; 91: 837-55.
138. Bordalo LA, Teixeira TF, Bressan J, Mourao DM. Bariatric surgery: how and why to supplement (Portuguese). Rev Assoc Med Bras 2011; 57: 113-20.